Samuel Weiss, PhD, FRSC, FCAHS

Ph.D. in Chemistry University of Calgary, Canada
B.Sc. in Biochemistry McGill University, Canada

Samuel Weiss

Areas of Research

Brain Tumour Stem Cell Biology and Experimental Therapeutics
The current research objective of the Weiss laboratory is to gain insights into the aberrant biological mechanisms of human brain tumour stem cells (BTSCs), derived from human glioblastoma (GBM) patients, that may lead to brain tumour initiation, therapeutic resistance and recurrence. We are currently focused on investigating human BTSCs at the metabolic, cell biologic, genomic and epigenomic levels to understand the mechanisms that may contribute to disease initiation and recurrence. We have developed in vivo translational approaches to examine novel experimental therapeutics and new drug therapy for GBM. Our goal is to test these new therapies in clinical trials for GBM, to improve outcomes for GBM patients.

Working with this supervisor

Graduate students with an interest in cancer biology, molecular biology, bioinformatics and in vivo model systems

Contact this supervisor

Complete the following form if you are interested in working with this supervisor for your Graduate Program. All fields are required, unless indicated otherwise.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.